EyePoint (EYPT) Shares Outstanding (2010 - 2026)

EyePoint (EYPT) reported Shares Outstanding (Entity) of $28.8 million for Q4 2021, up 124.04% on a YoY basis from $12.8 million in Q4 2020, and little changed sequentially from $28.8 million in Q3 2021.

EyePoint (EYPT) Shares Outstanding (2010 - 2026) Analysis & Trends

EyePoint (EYPT) has 12 years of Shares Outstanding (Entity) data on file, last reported at $28.8 million in Q4 2021.

  • For the quarter ending Q4 2021, Shares Outstanding (Entity) rose 124.04% year-over-year to $28.8 million; the trailing twelve-month figure through Dec 2021 stood at $28.8 million (up 124.04% YoY), and the FY2021 full-year result was $28.8 million, up 124.04% from the prior year.
  • Shares Outstanding (Entity) steadied at $28.8 million in Q4 2021, from $28.8 million in the prior quarter.
  • In the past five years, Shares Outstanding (Entity) ranged from a high of $28.8 million in Q3 2021 to a low of $3534.0 in Q2 2017.
  • A 5-year average of $12.2 million and a median of $10.7 million in 2019 frame the typical range for Shares Outstanding (Entity).
  • Across the five-year window, Shares Outstanding (Entity) sank 99.9% in 2017 and jumped 130703.62% in 2018, its largest moves.
  • Tracing EYPT's Shares Outstanding (Entity) over 5 years: stood at $4.5 million in 2017, then surged by 50.12% to $6.8 million in 2018, then soared by 61.05% to $10.9 million in 2019, then increased by 17.31% to $12.8 million in 2020, then surged by 124.04% to $28.8 million in 2021.
  • Business Quant data shows EYPT's Shares Outstanding (Entity) at $28.8 million in Q4 2021, $28.8 million in Q3 2021, and $28.8 million in Q2 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 6,012.74 Bn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 47.82 Bn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.44 Bn
4 NuCana 279.75 Bn 279.75 Bn - 11.23 Bn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 254.10 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 104.00 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - 400.00 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 62.19 Mn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 198.10 Mn
10 EyePoint 358.61 Mn 136.07 Mn 168,000.00 85,999.00

Historic Data

Download Data
DateValue
Mar 31, 2026 85,999.00
Dec 31, 2025 73,251.00
Sep 30, 2025 70,168.00
Jun 30, 2025 69,926.00
Mar 31, 2025 69.77 Mn
Dec 31, 2024 56,298.00
Sep 30, 2024 54.45 Mn
Jun 30, 2024 53.21 Mn
Mar 31, 2024 52,913.00
Dec 31, 2023 38.90 Mn
Sep 30, 2023 38.34 Mn
Jun 30, 2023 37.58 Mn
Mar 31, 2023 37.49 Mn
Dec 31, 2022 37.32 Mn
Sep 30, 2022 37.34 Mn
Jun 30, 2022 37.32 Mn
Mar 31, 2022 37.25 Mn
Dec 31, 2021 28.76 Mn
Sep 30, 2021 28.77 Mn
Jun 30, 2021 28.74 Mn